Top

World Journal of Urology

Published in:

01-04-2017 | Topic Paper

The rationale and the role of lymph node dissection in renal cell carcinoma

Authors: Umberto Capitanio, Bradley C. Leibovich

Published in: World Journal of Urology | Issue 4/2017

Abstract

Purpose

Although the role of lymph node dissection (LND) is well defined in many urological settings, uncertainty regarding need for LND still exists for patients with renal cell carcinoma (RCC). The aim of the current review is to highlight the rationale for performing or omitting LND at the time of renal surgery.

Methods

Data were identified through a search of PubMed and Web of Science, including studies published in the last 20 years in core clinical journals. The review is based on evidence synthesis from a peer-review process of the two authors after a structured data search.

Results

Neither imaging, nor predictive tools or molecular/genetic markers accurately identify which patients may warrant a LND. In patients with clinical T1abN0 and absence of unfavorable clinical and pathological characteristics, LND does not appear to offer benefit in terms of staging and cancer control. Conversely, LND can be considered in selected cases (larger tumors, locally advanced diseases or when unfavorable pathological characteristics are likely, as high Fuhrman grade, sarcomatoid features or tumor necrosis) due to the non-negligible risk of associated nodal metastases and possible benefit in terms of cancer control.

Conclusions

Although LND does not provide any benefit in the majority of RCC cases (mainly T1abN0M0 cases), it remains an important consideration in intermediate-/high-risk patients for staging purposes, given an increased risk of LNI, and for potential benefit in terms of cancer control. Additional data are urgently needed to improve the accuracy of nodal staging tools and to evaluate the potential role of salvage LND.

Blom JH, van Poppel H, Marechal JM, Jacqmin D, Schroder FH, de Prijck L et al (2009) Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol 55:28–34CrossRefPubMed

Capitanio U, Montorsi F (2016) Renal cancer. Lancet 387:894–906CrossRefPubMed

Kates M, Lavery HJ, Brajtbord J, Samadi D, Palese MA (2012) Decreasing rates of lymph node dissection during radical nephrectomy for renal cell carcinoma. Ann Surg Oncol 19:2693CrossRefPubMed

Studer UE, Birkhauser FD (2009) Lymphadenectomy combined with radical nephrectomy: to do or not to do? Eur Urol 55:35–37CrossRefPubMed

Parker A (1935) Studies on the main posterior lymph channels of the abdomen and their connections with the lymphatics of the genitourinary system. Am J Anat 56:409CrossRef

Brouwer OR, Noe A, Olmos RA, Bex A (2013) Lymphatic drainage from renal cell carcinoma along the thoracic duct visualized with SPECT/CT. Lymphat Res Biol 11:233–238CrossRefPubMed

Karmali RJ, Suami H, Wood CG, Karam JA (2014) Lymphatic drainage in renal cell carcinoma: back to the basics. BJU Int 114:806–817CrossRefPubMed

Assouad J, Riquet M, Foucault C, Hidden G, Delmas V (2006) Renal lymphatic drainage and thoracic duct connections: implications for cancer spread. Lymphology 39:26–32PubMed

Lughezzani G, Capitanio U, Jeldres C, Isbarn H, Shariat SF, Arjane P et al (2009) Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective. Cancer 115:5680–5687CrossRefPubMed

10.

Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM (2001) Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. J Urol 166:68–72CrossRefPubMed

11.

Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J et al (2003) Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol 169:2076–2083CrossRefPubMed

12.

Saitoh H, Nakayama M, Nakamura K, Satoh T (1982) Distant metastasis of renal adenocarcinoma in nephrectomized cases. J Urol 127:1092–1095PubMed

13.

Capitanio UB, Blute F, Mulders ML, Patard P, Russo JJ, Russo P, Studer UE, Van Poppel H (2011) Lymph node dissection in renal cell carcinoma. Eur Urol 60:1212CrossRefPubMed

14.

Hulten L, Rosencrantz M, Seeman T, Wahlqvist L, Ahren C (1969) Occurrence and localization of lymph node metastases in renal carcinoma. A lymphographic and histopathological investigation in connection with nephrectomy. Scand J Urol Nephrol 3:129–133CrossRefPubMed

15.

Johnsen JA, Hellsten S (1997) Lymphatogenous spread of renal cell carcinoma: an autopsy study. J Urol 157:450–453CrossRefPubMed

16.

Capitanio U, Montorsi F (2015) Renal cancer. Lancet 387(10021):894–906. doi:10.1016/S0140-6736(15)00046-X CrossRefPubMed

17.

Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H (2004) A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol 172:465–469CrossRefPubMed

18.

Capitanio U, Jeldres C, Patard JJ, Perrotte P, Zini L, de La Taille A et al (2009) Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma. BJU Int 103:33–37CrossRefPubMed

19.

Crispen PL, Breau RH, Allmer C, Lohse CM, Cheville JC, Leibovich BC et al (2011) Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. Eur Urol 59:18–23CrossRefPubMed

20.

Capitanio U, Suardi N, Matloob R, Roscigno M, Abdollah F, Di Trapani E et al (2014) Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC). BJU Int 114:210–215CrossRefPubMed

21.

Feuerstein MA, Kent M, Bazzi WM, Bernstein M, Russo P (2014) Analysis of lymph node dissection in patients with ≥7-cm renal tumors. World J Urol 32:1531–1536CrossRefPubMedPubMedCentral

22.

Terrone C, Guercio S, De Luca S, Poggio M, Castelli E, Scoffone C et al (2003) The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int 91:37–40CrossRefPubMed

23.

Bekema HJ, Maclennan S, Imamura M, Lam TB, Stewart F, Scott N et al (2013) Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma. Eur Urol 64:799CrossRefPubMed

24.

Schafhauser W, Ebert A, Brod J, Petsch S, Schrott KM (1999) Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy. Anticancer Res 19:1573–1578PubMed

25.

Margulis V, Wood CG (2008) The role of lymph node dissection in renal cell carcinoma: the pendulum swings back. Cancer J 14:308–314CrossRefPubMed

26.

Godoy G, O’Malley RL, Taneja SS (2008) Lymph node dissection during the surgical treatment of renal cancer in the modern era. Int Braz J Urol 34:132–142CrossRefPubMed

27.

Leibovich BC, Blute ML (2008) Lymph node dissection in the management of renal cell carcinoma. Urol Clin N Am 35:673–678CrossRef

28.

Capitanio U, Deho F, Dell’Oglio P, Larcher A, Capogrosso P, Nini A et al (2015) Lymphadenopathies in patients with renal cell carcinoma: clinical and pathological predictors of pathologically confirmed lymph node invasion. World J Urol. doi:10.1007/s00345-015-1747-5

29.

Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J et al (2003) Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy. Cancer 97:2995–3002CrossRefPubMed

30.

Whitson JM, Harris CR, Reese AC, Meng MV (2011) Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases. J Urol 185:1615–1620CrossRefPubMed

31.

Capitanio U, Volpe A (2015) Renal tumor biopsy: more dogma belied. Eur Urol 68:1014–1015CrossRefPubMed

32.

Feuerstein MA, Kent M, Bernstein M, Russo P (2014) Lymph node dissection during cytoreductive nephrectomy: a retrospective analysis. Int J Urol 21:874–879CrossRefPubMedPubMedCentral

33.

Kroeger N, Pantuck AJ, Wells JC, Lawrence N, Broom R, Kim JJ et al (2015) Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies. Eur Urol 68:506–515CrossRefPubMed

34.

Coll DM, Smith RC (2007) Update on radiological imaging of renal cell carcinoma. BJU Int 99:1217–1222CrossRefPubMed

35.

Turkvatan A, Akdur PO, Altinel M, Olcer T, Turhan N, Cumhur T et al (2009) Preoperative staging of renal cell carcinoma with multidetector CT. Diagn Interv Radiol 15:22–30PubMed

36.

Pushkar P, Agarwal A, Sarin A, Kashyap V (2015) Concurrent RCC with tuberculous para-aortic lymphadenopathy: a pleasant surprise. Can Urol Assoc J 9:E210–E212CrossRefPubMedPubMedCentral

37.

Connolly SS, Raja A, Stunell H, Parashar D, Upponi S, Warren AY et al (2015) Diagnostic accuracy of preoperative computed tomography used alone to detect lymph-node involvement at radical nephrectomy. Scand J Urol 49:142–148CrossRefPubMed

38.

Mueller-Lisse UG, Mueller-Lisse UL, Meindl T, Coppenrath E, Degenhart C, Graser A et al (2007) Staging of renal cell carcinoma. Eur Radiol 17:2268–2277CrossRefPubMed

39.

Sandrasegaran K, Sundaram CP, Ramaswamy R, Akisik FM, Rydberg MP, Lin C et al (2010) Usefulness of diffusion-weighted imaging in the evaluation of renal masses. AJR Am J Roentgenol 194:438–445CrossRefPubMed

40.

Gershman B, Takahashi N, Moriera DM, Thompson RH, Boorjian SA, Lohse CM et al (2016) Radiographic size of retroperitoneal lymph nodes predicts pathologic nodal involvement for patients with renal cell carcinoma: development of a risk prediction model. BJU Int. doi:10.1111/bju.13424

41.

Guimaraes AR, Tabatabei S, Dahl D, McDougal WS, Weissleder R, Harisinghani MG (2008) Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer. Urology 71:708–712CrossRefPubMed

42.

Ming X, Ningshu L, Hanzhong L, Zhongming H, Tonghua L (2009) Value of frozen section analysis of enlarged lymph nodes during radical nephrectomy for renal cell carcinoma. Urology 74:364–368CrossRefPubMed

43.

Kochhar R, Brown RK, Wong CO, Dunnick NR, Frey KA, Manoharan P (2010) Role of FDG PET/CT in imaging of renal lesions. J Med Imaging Radiat Oncol 54:347–357CrossRefPubMed

44.

Patard JJ, Fergelot P, Karakiewicz PI, Klatte T, Trinh QD, Rioux-Leclercq N et al (2008) Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma. Int J Cancer 123:395–400CrossRefPubMedPubMedCentral

45.

Ficarra V, Galfano A, Novara G, Iafrate M, Brunelli M, Secco S et al (2008) Risk stratification and prognostication of renal cell carcinoma. World J Urol 26:115–125CrossRefPubMed

46.

Divgi CR, Pandit-Taskar N, Jungbluth AA, Reuter VE, Gonen M, Ruan S et al (2007) Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncol 8:304–310CrossRefPubMed

47.

Bernie JE, Zupkas P, Monga M (2003) Intraoperative mapping of renal lymphatic drainage: technique and application in a porcine model. J Endourol 17:235–237CrossRefPubMed

48.

Bex A, Vermeeren L, de Windt G, Prevoo W, Horenblas S, Olmos RA (2010) Feasibility of sentinel node detection in renal cell carcinoma: a pilot study. Eur J Nucl Med Mol Imaging 37:1117–1123CrossRefPubMed

49.

Zisman A, Pantuck AJ, Dorey F, Chao DH, Gitlitz BJ, Moldawer N et al (2002) Mathematical model to predict individual survival for patients with renal cell carcinoma. J Clin Oncol 20:1368–1374CrossRefPubMed

50.

Babaian KN, Kim DY, Kenney PA, Wood CG Jr, Wong J, Sanchez C et al (2015) Preoperative predictors of pathological lymph node metastasis in patients with renal cell carcinoma undergoing retroperitoneal lymph node dissection. J Urol 193:1101–1107CrossRefPubMed

51.

Capitanio U, Abdollah F, Matloob R, Suardi N, Castiglione F, Di Trapani E et al (2013) When to perform lymph node dissection in patients with renal cell carcinoma: a novel approach to the preoperative assessment of risk of lymph node invasion at surgery and of lymph node progression during follow-up. BJU Int 112:E59–E66CrossRefPubMed

52.

Laguna MP (2014) Re: systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma. J Urol 191:1728–1729CrossRefPubMed

53.

Patard JJ (2006) Prognostic and biological significance of lymph node spreading in renal cell carcinoma. Eur Urol 49:220–222CrossRefPubMed

54.

Kroeger N, Seligson DB, Klatte T, Rampersaud EN, Birkhauser FD, Rao PN et al (2012) Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma. Eur Urol 61:888–895CrossRefPubMed

55.

Capitanio U, Becker F, Blute ML, Mulders P, Patard JJ, Russo P et al (2011) Lymph node dissection in renal cell carcinoma. Eur Urol 60:1212–1220CrossRefPubMed

56.

Russell CM, Espiritu PN, Kassouf W, Schwaab T, Buethe DD, Dhilon J et al (2014) Surgical outcomes in the management of isolated nodal recurrences: a multicenter, international retrospective cohort. J Urol 192:350–356CrossRefPubMed

57.

Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML (2008) Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy. J Urol 180:99–103 (discussion) CrossRefPubMed

58.

Capitanio U, Briganti A (2015) Words of wisdom. Re: surgical outcomes in the management of isolated nodal recurrences: a multicenter, international retrospective cohort. Eur Urol 67:974–975CrossRefPubMed

59.

Bekema HJ, MacLennan S, Imamura M, Lam TB, Stewart F, Scott N et al (2013) Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma. Eur Urol 64:799–810CrossRefPubMed

60.

Capitanio U, Matloob R, Suardi N, Abdollah F, Castiglione F, Di Trapani D et al (2012) The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma. Urologia 79:109–115CrossRefPubMed

61.

Hutterer GC, Patard JJ, Perrotte P, Ionescu C, de La Taille A, Salomon L et al (2007) Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram. Int J Cancer 121:2556–2561CrossRefPubMed

Title: The rationale and the role of lymph node dissection in renal cell carcinoma
Authors: Umberto Capitanio
Bradley C. Leibovich
Publication date: 01-04-2017
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 4/2017
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-016-1886-3

ACC 2024 Congress

Springer Medicine

The rationale and the role of lymph node dissection in renal cell carcinoma

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2017

Complications associated with ureterorenoscopy (URS) related to treatment of urolithiasis: the Clinical Research Office of Endourological Society URS Global study

Genetic variants in RNA-induced silencing complex genes and prostate cancer

Surgical control and margin status after robotic and open cystectomy in high-risk cases: Caution or equivalence?

Redefining the implications of nasogastric tube placement following radical cystectomy in the alvimopan era

Analysis of active surveillance uptake for low-risk localized prostate cancer in Canada: a Canadian multi-institutional study

Lymph node dissection in urological cancers: one topic, many controversies